133 related articles for article (PubMed ID: 24312514)
1. Disparity expression of Notch1 in benign and malignant colorectal diseases.
Huang R; Tang Q; You Q; Liu Z; Wang G; Chen Y; Sun Y; Muhammad S; Wang X
PLoS One; 2013; 8(12):e81005. PubMed ID: 24312514
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
Chu D; Zhang Z; Zhou Y; Wang W; Li Y; Zhang H; Dong G; Zhao Q; Ji G
Ann Oncol; 2011 Nov; 22(11):2440-2447. PubMed ID: 21378202
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.
Paiva TF; de Jesus VH; Marques RA; da Costa AA; de Macedo MP; Peresi PM; Damascena A; Rossi BM; Begnami MD; de Lima VC
BMC Cancer; 2015 Sep; 15():643. PubMed ID: 26394830
[TBL] [Abstract][Full Text] [Related]
5. The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis.
Li G; Zhou Z; Zhou H; Zhao L; Chen D; Chen H; Zou H; Qi Y; Jia W; Pang L
Future Oncol; 2017 Oct; 13(23):2103-2118. PubMed ID: 28984154
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
[TBL] [Abstract][Full Text] [Related]
7. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
8. A systematic analysis of the association between Notch1 expression and the patients with digestive tract cancers.
Zhang W; Chen H; Sun Z; Qiu C; Xiao J; Luo W; Liu D; Yan Z; Ou H; Wen X; Li G; Huang G
Biomark Med; 2018 Sep; 12(9):1049-1062. PubMed ID: 30043645
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
10. Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer.
Chu D; Zhou Y; Zhang Z; Li Y; Li J; Zheng J; Zhang H; Zhao Q; Wang W; Wang R; Ji G
Clin Cancer Res; 2011 Sep; 17(17):5686-94. PubMed ID: 21771876
[TBL] [Abstract][Full Text] [Related]
11. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.
Moussa M; Badawy A; Helal N; Hegab F; Youssef M; Aboushousha T; Al Faruok L; Elwy D
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2357-2366. PubMed ID: 32856866
[TBL] [Abstract][Full Text] [Related]
13. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
14. High level of Notch1 protein is associated with poor overall survival in colorectal cancer.
Chu D; Li Y; Wang W; Zhao Q; Li J; Lu Y; Li M; Dong G; Zhang H; Xie H; Ji G
Ann Surg Oncol; 2010 May; 17(5):1337-42. PubMed ID: 20058190
[TBL] [Abstract][Full Text] [Related]
15. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
Youssef HMK; Radi DA; Abd El-Azeem MA
Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
[No Abstract] [Full Text] [Related]
16. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
17. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
18. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
19. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.
Kim HA; Koo BK; Cho JH; Kim YY; Seong J; Chang HJ; Oh YM; Stange DE; Park JG; Hwang D; Kong YY
J Clin Invest; 2012 Sep; 122(9):3248-59. PubMed ID: 22863622
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
